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The article by Haldorsen et al.
1 describes a genetic association study for primary Sjö gren's syndrome (pSS), and the FCGR gene cluster on Chr1q22. The study evaluated both genomic copy number variation (CNV) in the FCGR3B gene, and four singlenucleotide polymorphisms (SNPs) in FCGR2A, FCGR3A and FCGR3B, respectively. No associations were observed.
Copy number variation has been identified in multiple genes in the FCGR gene cluster, 2 but perhaps the best characterized in FCGR3B. Individuals may carry 0, 1, 2, 3 or 4 copies of FCGR3B, indicating that a single chromosome may carry a deletion or a duplication of the gene. In recent years, a convincing body of evidence has accumulated demonstrating that low FCGR3B copy number (that is, 0 or 1 copy, or carriage of a FCGR3B deletion on at least one chromosome) is associated with susceptibility to systemic autoimmune disease (reviewed in the study by  McKinney and Merriman   3   ) , and in particular, systemic lupus erythematosus (SLE). As there is considerable clinical, serological and genetic overlap between SLE and pSS, characterization of the association between low FCGR3B and pSS is of great interest. While the Haldorsen et al.
1 study, which examined FCGR3B CNV in Norwegian pSS patients, was negative, two previously published studies have both reported an association between low FCGR3B copy number and pSS in American 4 and Australian 5 cohorts, and we were the authors of this latter study. Haldorsen et al. 1 suggest that the discrepancy between our two studies is due to technical superiority of their study (in terms of a small difference in the stringency of the allowable standard deviation of the replicate DCq values), or the fact that our controls were not gender matched (without providing a rationale for suggesting there will be a gender difference in autosomal FCGR3B CNV genotype frequencies in the controls). However, there are more profound differences between these two studies, and we believe it is the validity of the Haldersen et al.
1 study that is in doubt.
All three studies of FCGR3B CNV in pSS employed quantitative PCR assays and fluorescent probe-based chemistry, which enables duplex reactions for FCGR3B and the reference gene, albeit with differences in the primer and probe design and the choice of reference genes. Gene copy number occurs in discrete, integer values and unfortunately, Haldorsen et al. did not, or could not, assign clear genotype FCGR3B copy numbers from their assay, for reasons which the authors did not explain. Instead they relied on analyzing standardized DCq values as a continuum, without any apparent adjustment for test batch differences, which is an important confounder. This is the analysis approach used in early studies where difficulties were encountered in copy number assignment when using Sybr Green chemistry and single-plex reactions. This suggests that the Haldorsen et al. assay was not optimal, and further, makes it is impossible to truly compare the actual results with the two previous studies in American 4 and Australian 5 pSS patients. Notably, these previous pSS studies reported very similar FCGR3B CNV genotype frequencies in the controls, which were similar to the control data (from comparable populations) from other studies (reviewed in the study by McKinney and Merriman 3 ). Further, these previous two studies reported virtually identical effect sizes for the association between low FCGR3B CNV and pSS. 4, 5 These issues aside, the incontrovertible flaw in the Halderson et al. FCGR3B CNV assay becomes apparent on inspection of the primers utilized (Figure 1 ). These primers amplify a 78-base pair fragment in both FCGR3B and FCGR3A, which are identical in sequence, and therefore the assay is not specific. To further complicate matters, FCGR3A also exhibits CNV, 2 and the results cannot simply be interpreted as FCGR3B CNV. This may also provide an explanation for the apparent difficulty in assigning gene copy number. In this assay, individuals are expected to carry between 0 and 8 combined copies of FCGR3B þ FCGR3A, and it is difficult to discriminate these higher copy numbers by quantitative PCR as the differential in Cq values (that is, DDCq) between increasing gene copies decreases as the gene copy number increases.
The FCGR locus originated from segmental duplication and crossover events, which resulted in high homology between the five FCGR genes. 6 The lack of specificity of the Halderson et al. FCGR3B CNV assay is a direct result of the high degree of homology between FCGR3B and FCGR3A, making it difficult to design specific genotyping assays. Further, the SNPs in this region are poorly characterized and poorly mapped, and it is therefore likely that the FCGR SNP results reported by Halderson et al. may be flawed as well. For example, the four SNPs studies are all mapped ambiguously in the human reference genome, and two of them rs448740 (FCGR3B) and rs396991 (FCGR3A) are red flagged on dbSNP as suspected errors. It is not clear where the SNPs are located, and it is not clear whether the genotyping assays are specific, it is not clear whether SNPs may be carried on multiple copies, where CNV exists, and it therefore is not clear how SNP frequencies should be calculated and analyzed.
Currently, the balance of evidence, from two previous studies, suggests that low FCGR3B copy number is associated with pSS, Figure 1 . The Haldorsen et al. quantitative PCR assay for FCGR3B copy number variation is not specific. The primers amplify 78-base pair fragments from both FCGR3A and FCGR3B, which are identical in sequence. The assay is therefore predicted to detect a combination of FCGR3B þ FCGR3A gene copies. The primer sequences are shaded in gray, and the fluorescent probe binding sequence is underlined. The base positions are from the human genome assembly for GRCh37.p12. similar to other systemic autoimmune diseases. However, further studies are needed to confirm this association. The Halderson et al. study was a potentially important contribution to this field, and it is regrettable that it was not informative.
